ClinicalTrialsFinder

Oligometastatic Non-small Cell Lung Cancer (NSCLC) Clinical Trials

0 recruiting

Showing 1–1 of 1 trials

Recruiting
Phase 3

First-line Immunotherapy-based Standard of Care and Local Ablative Treatments for Oligometastatic Non-small Cell Lung Cancer Patients.

Oligometastatic Non-small Cell Lung Cancer (NSCLC)
Gustave Roussy, Cancer Campus, Grand Paris124 enrolled3 locationsNCT06840782